Supply Chain

This prototype machine produces 1,000 pills in 24 hours, faster than it can take to produce some batches in a factory. Allan Myerson, a professor of chemical engineering at MIT and a leader of the effort, says it could become eventually an option for anyone who makes medications, which typically require a lengthy and complex process of crystallization.

While surgical screws or sponges can cost a hospital less than a penny each, when a surgeon accentially leaves one of these behind in a patient's body the mistake can cost both patientsa and healthcare providers dearly.

A new study by the CVS Health Research Institute found that home infusion care is safe, clinically effective and improves quality of life; and when it's compared to infusion care delivered in a hospital or clinic, it may also reduce healthcare costs.

The Centers for Medicare and Medicaid Services has made public a "lightly redacted" copy of the letter it sent to beleaguered blood-testing company Theranos on March 18, with newly revealed allegations that its proprietary testing devices often failed to meet the company's own accuracy requirements for certain tests -- in one instance, failing to accurately detect prostate cancer.

Transparency in how drug companies set pricing is needed to reform the pharmaceuticals industry, The Campaign for Sustainable Drug Pricing claims in a new series of proposals aimed at making the prescription drug marketplace more open and competitive.

At Baltimore-based Johns Hopkins Health System, achieving scale meant creating a system-wide supply chain infrastructure rather than allowing each facility to oversee its own device purchasing.

The era of value-based reimbursement is making patient satisfaction a costly thing to ignore, and that goes for the operating room right down to the hospital cafeteria.

When California's aid-in-dying law takes effect this June, terminally ill patients who decide to end their lives could be faced with a hefty bill for the lethal medication. It retails for more than $3,000.

The U.S Food and Drug Administration has proposed a ban on most of the powdered medical gloves in use throughout the country, claiming they pose a risk of illness or injury to healthcare providers, patients and others individuals who are exposed to them.

Healthcare Supply Chain Association President and CEO Todd Ebert has praised the U.S. Food and Drug Administration's decision to prioritize abbreviated new drug applications for generic drugs with only one manufacturer, sometimes known as "sole source" products.